KUALA LUMPUR, March 12 -- PRA Health Sciences has announced a partnership between its wholly-owned subsidiary, Symphony Health and Datavant, resulting in the deepest and most holistic view of the patient journey in the commercial market.
According to a statement, life sciences customers will gain flexibility to build bespoke, fit-for-purpose data assets and strategies to support the development and delivery of life-enhancing drugs.
Symphony Health’s proprietary Synoma® de-identification engine enables integration of complementary data sets from across the health ecosystem using a unique token.
By working closely with Datavant, Symphony Health gives its customers the flexibility to connect data integrated via Synoma to the hundreds of unique data sets available via Datavant.
By leveraging best-in-class de-identification and integration with Symphony Health’s proprietary Synoma engine, customers will be able to connect, expand and analyse all relevant data types.
Leveraging these integrated data sets, customers can then build bespoke, fit-for-purpose data assets, custom data strategies and develop unique insights for their business with support from PRA and Symphony data experts.
-- BERNAMA
No comments:
Post a Comment